Instead, activating mutations in SF3B1 and KIT, loss of CDKN2A, PTEN, or SPRED1, as well as amplification of CDK4, TERT, KIT, MDM2, or CCND1, are more common in MM (16). Here, PTEN is linked to Miyoshi myopathy.